HCM
MED icon

Hoplite Capital Management’s Medifast MED Stock Holding History

Hoplite Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-408,828
Closed -$52.5M – 16
2019
Q2 		$52.5M Buy
408,828
+146,568
+56% +$20.4M 7.17% 3
2019
Q1 		$33.5M Buy
+262,260
New +$33.3M 4% 10

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Hoplite Capital Management's MED Position: Q3 2019 in Review

Hoplite Capital Management sold out of Medifast (MED) in Q3 2019, closing a stake of 408,828 shares — an estimated $52.5M sold.

Hoplite Capital Management first reported a position in MED in Q1 2019 and held it in 2 quarters. The position peaked at $52.5M in Q2 2019. 239 funds tracked by Wall St. Rank hold MED as of Q3 2019.

  • Hoplite Capital Management reported no remaining Medifast position as of Q3 2019 after selling out during the quarter.
  • Hoplite Capital Management sold 408,828 Medifast shares in Q3 2019, an estimated $52.5M.
  • Hoplite Capital Management first reported a position in Medifast in Q1 2019 and held it in 2 quarters.
  • Hoplite Capital Management's Medifast position peaked at $52.5M in Q2 2019.
  • 239 funds tracked by Wall St. Rank held Medifast as of Q3 2019.

Based on Hoplite Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.